See how IPA can help you: Start a free, two-week trial of IPA
IPA® is software that enables cardiovascular disease researchers to better understand the biological and chemical systems at the core of life science research. With IPA, researchers can analyze ‘omics data, search for targeted biological and chemical information, and build their own biological models. IPA provides researchers with access to a wealth of information on genes involved in cardiovascular-related processes and pathways, drug targets, as well as the tools necessary to discover new disease targets and markers of disease and drug efficacy.
The powerful capabilities of IPA are a direct result of the uniquely structured biological and chemical Findings in the Ingenuity® Knowledge Base. These Findings are structured, manually reviewed relationships that have been published in hundreds of peer-reviewed journals, including Journal of Lipid Research, Atherosclerosis, Hypertension, Journal of Experimental Medicine, Nature Medicine, Nature Genetics, and many others.
The powerful capabilities of IPA are a direct result of the uniquely structured biological and chemical Findings in the Ingenuity® Knowledge Base. These Findings are structured, manually reviewed relationships that have been published in hundreds of peer-reviewed journals, including Journal of Lipid Research, Atherosclerosis, Hypertension, Journal of Experimental Medicine, Nature Medicine, Nature Genetics, and many others.
See how IPA has contributed to cardiovascular disease research by downloading our "Applying IPA: Cardiovascular Disease" packet.
Learn more about IPA on our website, www.ingenuity.com
Click here to register for a free, fully functional two-week trial of IPA.
Click here to register for a free, fully functional two-week trial of IPA.